financetom
Business
financetom
/
Business
/
Corteva targets fourth quarter for planned split into two companies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Corteva targets fourth quarter for planned split into two companies
Mar 11, 2026 5:31 AM

Feb 25 (Reuters) - U.S. agrichemicals company Corteva ( CTVA ) said it expects the previously announced planned separation into two listed ​companies to occur sometime ‌in the fourth quarter of this year.

Late last year, ⁠the company had said it would ⁠separate its seed and pesticide ‌businesses as ‌it seeks to sharpen its strategic focus.

Corteva ( CTVA ) CEO Chuck ​Magro said at ‌the BofA Global Agriculture and Materials Conference that the company would ​announce headquarters, senior leadership ​teams ‌and the CEO of New Corteva in the first half of this year.

The ⁠company's executives added that they are ⁠optimistic about the future of the crop protection industry, citing steady demand growth and potential for further consolidation.

"We're seeing ⁠strong ‌demand, essentially around the world, ‌but there's going to be some continued ⁠headwinds, in price, but volume should more than offset it," one of the senior executives said at the conference.

Corteva ( CTVA ) said that positive momentum from a policy perspective in ​the U.S. could benefit not only the domestic soybean market but also canola and ​mustard.

(Reporting by Pooja ‌Menon in Bengaluru; Editing by ​Maju Samuel)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novartis, Monte Rosa strike $5.7 billion drug development deal
Novartis, Monte Rosa strike $5.7 billion drug development deal
Sep 15, 2025
Sept 15 (Reuters) - Swiss drugmaker Novartis and drug developer Monte Rosa Therapeutics ( GLUE ) signed a licensing deal worth up to $5.7 billion on Monday to develop drugs for immune-mediated diseases. ...
Avicanna Names Nick Hilborn Interim CFO After Phillip Cardella Becomes Consultant
Avicanna Names Nick Hilborn Interim CFO After Phillip Cardella Becomes Consultant
Sep 15, 2025
07:11 AM EDT, 09/15/2025 (MT Newswires) -- Avicanna ( AVCNF ) , a biopharmaceutical company focused on plant-derived cannabinoid products, said over the weekend it appointed vice president of finance Nick Hilborn as interim chief financial officer. The move follows Phillip Cardella's transition to consultant effective Sept. 15, the company said. Hilborn joined Avicanna ( AVCNF ) in 2024. ...
Underwater sonar tech firm Coda Octopus' Q3 revenue up 29% 
Underwater sonar tech firm Coda Octopus' Q3 revenue up 29% 
Sep 15, 2025
Overview * Coda Octopus ( CODA ) fiscal Q3 revenue grows 29% yr/yr * Company's Marine Technology Business revenue rises 30.7%, Marine Engineering declines * Gross margin falls to 68.3% from 73.9% due to business mix changes Outlook * Company expects DAVD sales of $3.5 mln-$4.0 mln for fiscal year 2025 * Coda Octopus ( CODA ) anticipates U.S. energy...
Snacks and food maker Hain Celestial misses Q4 sales estimates, sets turnaround strategy
Snacks and food maker Hain Celestial misses Q4 sales estimates, sets turnaround strategy
Sep 15, 2025
(Corrects company descriptor and adds turnaround strategy in headline) Overview * Hain Celestial ( HAIN ) fiscal Q4 net sales down 13% yr/yr, missing analyst expectations * Adjusted net income for fiscal Q4 missed analyst estimates, reflecting operational difficulties * Co implements turnaround strategy focusing on portfolio streamlining and digital capabilities Outlook * Company aims to optimize cash and reduce...
Copyright 2023-2026 - www.financetom.com All Rights Reserved